User profiles for Rozita Khodashahi
 | Rozita khodashahiID Specialist Fellowship in IC host & transplant patients, Head of Infectious Diseases … Verified email at mums.ac.ir Cited by 3120 |
Ocular manifestations of hospitalized patients with COVID-19 in Northeast of Iran
…, H Naderi, A Bojdy, R Khodashahi… - Ocular immunology …, 2020 - Taylor & Francis
Purpose To evaluate ocular findings in patients with Coronavirus Disease 2019 (COVID-19)
in the Northeast of Iran. Methods In a cross-sectional, observational study all consecutive …
in the Northeast of Iran. Methods In a cross-sectional, observational study all consecutive …
Early lactate area scores and serial blood lactate levels as prognostic markers for patients with septic shock: a systematic review
R Khodashahi, S Sarjamee - Infectious Diseases, 2020 - Taylor & Francis
Septic shock is the main cause of morbidity and mortality in patients and second leading
cause of mortality among subjects in noncoronary intensive care units. Based on the literature, …
cause of mortality among subjects in noncoronary intensive care units. Based on the literature, …
Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial
…, SA Javad-Mousavi, R Khodashahi… - International …, 2020 - Elsevier
Potential therapeutic approaches in coronavirus disease 2019 (COVID-19) comprise antiviral
and immunomodulatory agents; however, no immunomodulator drug has been approved. …
and immunomodulatory agents; however, no immunomodulator drug has been approved. …
Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical …
Objective To report the efficacy, safety, and exploratory immunogenicity findings of two 5 µg
doses of the BIV1-CovIran vaccine. Design Randomised, placebo controlled, double blind, …
doses of the BIV1-CovIran vaccine. Design Randomised, placebo controlled, double blind, …
[HTML][HTML] COVID-19 cases, hospitalizations and deaths after vaccination: a cohort event monitoring study, Islamic Republic of Iran
Objective To investigate the incidence of coronavirus disease 2019 (COVID-19) cases,
hospitalizations and deaths in Iranians vaccinated with either AZD1222 Vaxzevria, CovIran® …
hospitalizations and deaths in Iranians vaccinated with either AZD1222 Vaxzevria, CovIran® …
[HTML][HTML] Intravenous immunoglobulin for treatment of patients with COVID-19: a case-control study
R Khodashahi, HR Naderi, A Sedaghat… - Archives of Clinical …, 2021 - brieflands.com
Background: It seems that the risk of developing complications associated with coronavirus
disease 2019 (COVID-19) is higher among individuals with weakened immune systems. …
disease 2019 (COVID-19) is higher among individuals with weakened immune systems. …
The Association between Circulating Adipocytokine Omentin Levels and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
Background: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver
condition worldwide. NAFLD is often associated with features of Metabolic Syndrome such as …
condition worldwide. NAFLD is often associated with features of Metabolic Syndrome such as …
[HTML][HTML] Evaluation of the anti-inflammatory effects of atorvastatin on patients with rheumatoid arthritis: a randomized clinical trial
ZS Sarabi, MG Saeidi, M Khodashahi… - Electronic …, 2016 - ncbi.nlm.nih.gov
Background Rheumatoid arthritis (RA) is a chronic inflammatory joint disorder with unknown
etiology. Atorvastatin is a lipid-lowering agent that affects the inflammatory processes. …
etiology. Atorvastatin is a lipid-lowering agent that affects the inflammatory processes. …
[HTML][HTML] The Association Between the Gut Microbiome and COVID-19 Severity: The Potential Role of TMAO Produced by the Gut Microbiome
Context: The COVID-19 pandemic has had profound impacts on public health, resulting in
nearly 1 million deaths. Emerging evidence suggests an association between certain …
nearly 1 million deaths. Emerging evidence suggests an association between certain …
Comparison the effect of arbidol plus hydroxychloroquine vs hydroxychloroquine alone in treatment of COVID-19 disease: a randomized clinical trial
R Khodashahi, H Naderi, A Bojdy… - Current Respiratory …, 2020 - ingentaconnect.com
Background and Aim: The main challenging issue about coronavirus disease 2019 (COVID-19)
is the production of safe and stable vaccines, which is a very long process. Due to the …
is the production of safe and stable vaccines, which is a very long process. Due to the …